Cantitate/Preț
Produs

Liver Cancer: New Research

Editat de Felix Lee
en Limba Engleză Hardback – sep 2005
Primary liver cancer occurs when cancerous (malignant) cells begin to grow in the tissues of liver. Although many cancers are on the decline, the incidence of primary liver cancer in the United States increased over 70 percent between 1975 and 1995. The increase is linked to rising rates of hepatitis B and C infection -- the leading causes of liver cancer. Far more common than primary liver cancer, however, is cancer that occurs when tumours from other parts of the body spread (metastasize) to the liver. The liver is especially vulnerable to invasion by tumour cells and with the exception of the lymph nodes, is the most common site of metastasis. There are two main kinds of liver cancer. Hepatoma and cholangiocarcinoma. Heptoma is cancer of the hepatocytes. (The main functioning liver cell). Hepatoma is primary liver cancer. Hepatoma usually grows in the liver as a ball-like tumour, invading the normal tissue surrounding it. Cancer of the bile duct cells is called cholangiocarcinoma. Cholangiocarcinoma originates in the bile ducts and is often caused by infestation with the liver fluke Clonorchis (a parasite). The cancer grows along the bile ducts in sheets or lines, and is difficult to find on X-ray studies. This book presents the latest new research developments from around the world in the field of liver cancer.
Citește tot Restrânge

Preț: 96098 lei

Preț vechi: 131888 lei
-27% Nou

Puncte Express: 1441

Preț estimativ în valută:
18393 19170$ 15311£

Carte disponibilă

Livrare economică 16-30 decembrie

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781594541827
ISBN-10: 1594541825
Pagini: 266
Ilustrații: tables & charts
Dimensiuni: 260 x 180 x 24 mm
Greutate: 0.83 kg
Ediția:New.
Editura: Nova Science Publishers Inc
Colecția Nova Science Publishers, Inc (US)

Cuprins

Preface; Malignant Epithelial Liver Tumours in Children, Adolescents, and Adults: Molecular Pathways of Cancerogenesis, Growth, and Spread; Tumour Biology of Colorectal Liver Metastases; Colorectal Cancer Liver Metastases: Destruction or Resection?; Strategies for Inferior Phrenic Arteriography and Transcatheter Arterial Chemoembolisation in Patients with Hepatocellular Carcinoma; MDM-2 Over-Expression in Hepatitis B x Antigen Positive Hepatocellular Carcinoma; Understanding Mechanisms of Hepatocarcinogenicity of the Breast Cancer Drug Tamoxifen at the Molecular Level: Relative Risks to Women versus Rodents; Immunotherapy in Metastic Liver Disease; Cancer Surveillance Following Orthotopic Liver Transplantation; Angiogenesis Related Factore in Hepatocellular Carcinoma and Anti-Angiogenesis Therapy; Research on Angigenesis in Liver Cancer and Its Clinical Implications; Index.